DiaBeat: The Beating Heart of Diabetes (8th session)

8th Diabetes Masterclass for Cardiologists

Save the date: Late-breaking Science in Cardiovascular disease prevention

ESC 2021 cardiovascular prevention guideline lectures and discussion

Save the date; Cardiorenal Metabolic Crossroads: case-based panel discussion

The second session of Cardiorenal metabolic crossroads program

Save the date: 20th case-based ECG interpretation workshop

20th ECG workshop for medical and nursing trainees

Save the date: 2021 post ESC Headlines

Ground-breaking research from ESC 2021

The clinical landscape for Diabetes and Cardiovascular disease

T2DM and cardiovascular diseases: The clinical landscape

Introducing the Umbrella CCS event

Umbrella CCS is underway

DiaBeat: The Beating Heart of Diabetes (7th session), a scientific debate

7th Diabetes Masterclass for Cardiologists

From optimal medical therapy to revascularization in CCS

Choosing the best therapeutic strategy in CCS

Antithrombotic lighthouse, Cases and Faces: antithrombotic therapy in CAD

Antithrombotic regimens in CAD

Finding the optimal thromboprophylaxis regimen in patients with COVID-19

Preventing thromboembolic events in COVID-19

Umbrella: focused cardiology forums

New series by Daily Cardiology Academy: Umbrella

Save the date: Diabeat: 7th session, SGLT2 Inhibitors for Primary Prevention of CVD

7th diabeat masterclass for cardiologists: SGLT2i in CVD primary prevention

Save the date: Finding the optimal thromboprophylaxis regimen in patients with COVID-19

thromboprophylaxis in COVID-19

Save the date: Umbrella, Focused cardiology forums

The first session of Umbrella series

Tailored Antithrombotic therapy for CCS patients

Best individual antithrombotic strategy in CCS

Save the date: 19th case-based ECG interpretation workshop

19th ECG workshop for medical and nursing trainees

Cardio-Watch Podcast: Episode 5, cardiometabolic disorders

The fifth episode of Cardio-Watch: cardiometabolic disorders

Testing for Iron deficiency and use of Ferric Carboxymaltose in HF patients

Diagnosis and management of Iron deficiency in HF patients

Cardiometabolic Grand Round: 4th session

Guideline-directed cardiovascular evaluations before surgery

Cardiovascular complications of T2DM: the preventive role of SGLT2Is

SGLT2Is and the prevention of cardiovascular complications in T2DM

DCS 1400: session 2, Diabetes for cardiologists

The second panel of DCS 1400: diabetes for cardiologists

DCS 1400: session 1, HTN and DLP

The first panel of DCS 1400: hypertension and dyslipidemia

Save the date: Diabetes On Target (DOT): the latest updates

Cardio-Watch podcast: Episode 3, Atrial fibrillation and Flutter

The Third episode of Cardio-Watch: AF

Save the date: Cardiometabolic Grand Round 4th session

The fourth session of Cardiometabolic grand round

How to reduce the atherosclerotic cardiovascular risk

A case-based Review on HTN and DLP management

Updates on the management of Diabetes and cardiometabolic disease

Actoverco Diabetes Lunch Webinar

The evolution of antiplatelet therapy in CAD: a 45 year journey

A brief history of anti-platelet therapy in CAD

Dual antiplatelet therapy in2021: Current recommendations

The latest updates on DAPT

Impact: the paradox of physical activity in cardiovascular disease

The contemporary Copenhagen general population study

DiaBeat: The Beating Heart of Diabetes (5th session)

5th Diabetes Masterclass for Cardiologists

Daily Cardiology Symposium 1400. Concise, Precise, Practical

Case-based review of common cardiovascular practice The digital experience

Dual RAAS inhibition in the treatment of systolic heart failure; at a glance Part two: Eplerenone in the guidelines

Latest guideline recommendations on the use of RAAS inhibitors in heart failure patients

Dual RAAS inhibition in the treatment of systolic heart failure; at a glace Part one: Eplerenone in the pipeline

Latest pieces of evidence regarding the use of RAAS inhibitors in heart failure patients

Case Discussion (31)

Calcium channel blocker related edema

Save the date: Daily Cardiology Symposium 1400

Case-based review of common cardiovascular practice

Cardiometabolic Grand Round (3)

A brief talk on DM medication challenges in patients with CVD

An introduction to daily cardiology academy symposium; a digital learning opportunity

Invitation for attending the symposium by executive directors

Guideline Directed Medical Therapy in Patients with HF

Quick review on place of MRAs in patients with HFrEF

CardioPoint (10): The growing burden of cardiovascular diseases

Emphasizing the importance of CVD prevention and management

Introduction: Evolution of DOACs and their place in Guidelines

A brief report of Guidelines mentioned DOACs place in practice

Save the date: To DOAC or Not To DOAC

Rapid review of oral Anticoagulation practice in different clinical scenarios

10th Case: Drug Drug Interactions

DOACs important interactions in clinical practice

To DOAC or Not to DOAC

Rapid review of oral anticoagulation practice in different clinical scenarios

9th Case: Renal Insufficiency

OAC Management in Patients with CKD

Seventh Case: Thrombocytopenia

Any Concerns for OACs Use in Patients with Thrombocytopenia

Sixth Case: Hepatic Impairment

OAC of choice in patients with hepatic impairment, any difference between DOACs?

Second Case: Cancer associated VTE

Anticoagulation of choice in patients with cancer, the importance of DDI

Save the date: 1st Daily Cardiology Symposium

Case-based review of common cardiometabolic practice

Complete Session;SGLT2 inhibition: Making waves in the heart failure landscape

Role of SGLT2 inhibitors in HF patients from two perspectives: Endocrinology & Cardiology

SGLT2 inhibitors in the treatment of HF: the future is bright?

Cardiologist Perspective on SGLT2 inhibitors

SGLT2 inhibition: A snapshot into their evolution

Endocrinologist Perspective on SGLT2 inhibitors

SGLT2 inhibition: Making waves in the heart failure landscape

Role of SGLT2 inhibitors in HF patients from two perspectives: Endocrinology & Cardiology

Save the date: SGLT2 inhibition: Making waves in the heart failure landscape

Role of SGLT2 inhibitors in HF patients from two perspectives: Endocrinology & Cardiology

Save the date: Cardiometabolic Grand Round (2)

A brief talk on DM medication challenges in patients with CVD

Impact: EMPA-RESPONSE-AHF

Empagliflozin effects on clinical outcomes in patients with ADHF (EMPA-RESPONSE-AHF)

Cardiometabolic Grand Round (2)

A brief talk on DM medication challenges in patients with CVD

A Polypill For the Prevention of CVD in Intermediate Risk Patients: Results of the International Polycap Study (TIPS-3 Trial)

A quick review on the findings of TIPS-3 trial from AHA congress 2020

Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients with T2DM and Moderate Renal Impairment Who Are at Cardiovascular Risk (SCORED)

The Important findings of SCORED trial from AHA 2020 congress in brief

High Dose Vs Standard Dose Influenza Vaccine in Patients with a High-Risk for Cardiovascular Disease (INVESTED)

A quick review on the findings of INVESTED trial from AHA congress 2020

Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor+ASA for Prevention of Stroke and Death (THALES Trial)

The effects of Ticarelor+ASA in Acute Stroke

Sotagliflozin and Cardiovascular Events in T2DM Post Worsening HF (SOLOIST-WHF)

Sotagliflozin in T2DM and exacerbated HF

Ferric Carboxymaltose for iron deficiency at discharge after acute heart failure (AFFIRM-AHF)

Iron supplementation in acute heart failure

Finerenone Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease (FIDELIO-DKD Trial)

Finerenone protecting kidneys

Save the date: Cardiometabolic Grand Round

A brief talk on DM management in patients with CVD

Cardiometabolic Grand Round (1)

A brief talk on DM management in patients with CVD

Monitor eGFR in Patients Treated with Metformin

KDIGO 2020 Clinical Practice Guideline for DM Management in CKD

Patient factors influencing the selection of glucose-lowering drugs other than SGLT2i and metformin in T2D and CKD

KDIGO 2020 Clinical Practice Guideline for DM Management in CKD

Glycemic Management for patients with T2DM and CKD

KDIGO 2020 Clinical Practice Guideline for DM Management in CKD

Monitoring of ACEI/ ARB Treatment in Patients with T2DM and CKD

KDIGO 2020 Clinical Practice Guideline for DM Management in CKD

Save the date: Comprehensive risk reduction in DM

Collaborative management of DM: Endocrinologist, Nephrologist and Cardiologist team work

How to Implement the Newest Diabetes Therapies in HF Treatment

New insight from EMPEROR Reduced Trial

Save the Date: What we learned from ESC Congress about HTN Management

A Brief Discussion on HTN Management Pearls of ESC 2020

Save the date: VTE Prophylaxis in Patients with COVID-19

Challenges on VTE Prophylaxis in different settings (inpatient, outpatient, upon discharge)

VTE Prophylaxis in Patients with COVID-19

Challenges on VTE Prophylaxis in different settings (inpatient, outpatient, upon discharge)

Diabetes and Cardiovascular Diseases

On the occasion of World Heart Day 2020 for the management of Cardiovascular risk factors

Smoking and the Heart the Struggle Continues

On the occasion of World Heart Day 2020 for the management of Cardiovascular risk factors

The weight of the world: The global challenge of obesity

On the occasion of World Heart Day 2020 for the management of Cardiovascular risk factors

Ground-breaking research from ESC Congress 2020 (21)

Part Twenty-One: Trial Review, BPLTTC (CANCER)

Ground-breaking research from ESC Congress 2020 (17)

Part Seventeen: Trial Review, REALITY

Ground-breaking research from ESC Congress 2020 (15)

Part Fifteen: Trial Review, PARALLAX

Ground-breaking research from ESC Congress 2020 (11)

Part Eleven: Trial Review, DAPA-CKD

Ground-breaking research from ESC Congress 2020 (10)

Part Ten: Trial Review, DECLARE-TIMI

Ground-breaking research from ESC Congress 2020 (4)

Part Four: Trial Review, BRACE-CORONA

Ground-breaking research from ESC Congress 2020 (3)

Part Three: Trial Review; THEMIS, PAD

Ground-breaking research from ESC Congress 2020 (2)

Part Two: Trial Review, EMPEROR-REDUCED

Save the date: Daily Cardiology Journal Club: 3rd Session – EMPEROR-REDUCED Trial

Monthly Case-Based Clinical Problem Solving

Daily Cardiology Journal Club: 3rd Session – EMPEROR-REDUCED Trial

Monthly Case-Based Clinical Problem Solving

Save the date: Ground-breaking research from ESC Congress 2020

Brief Review of Main Trials Discussed in ESC Congress 2020

Ground-breaking research from ESC Congress 2020

Brief Review of Main Trials Discussed in ESC Congress 2020

Impact: Colchicine in patients with acute coronary syndrome

The findings of COPS trial

Impact: Colchicine in patients with chronic coronary syndrome

The findings of LoDoCo2 trial

Impact: cardiovascular and renal outcomes of Empagliflozin in HF

The findings of EMPEROR-REDUCED trial

Save the date: Shielding the Brain From Stroke

A case based discussion on optimization of antithrombotic therapy in patients with ischemic stroke

Shielding the Brain From Stroke

A case based discussion on optimization of antithrombotic therapy in patients with ischemic stroke

Save the date: Current Cardiology Practice of Antithrombotics in ASCVD: A Case Based Panel Discussion

Brief discussion on choice of antithrombotic agents in patients with chronic coronary syndrome and peripheral artery disease

Current Cardiology Practice of Antithrombotics in ASCVD: A Case Based Panel Discussion

Brief discussion on choice of antithrombotic agents in patients with chronic coronary syndrome and peripheral artery disease

Pharmacological approach to ACS management in patients on DOAC

Challenges on fibrinolytic therapy and primary PCI issues in admitted ACS patients on DOACs

Case Discussion (27)

Vitamin D Supplementation in Patients with Severe CAD